Hot Investor Mandate: Shanghai PE Firm Invests Up to $10M in Emerging Medical Technology and Diagnostics Companies with Potential for China Market Entry

2 Aug

A China-focused investment firm based in Shanghai seeks to invest in emerging Medical Technology and Diagnostics companies at near commercial or commercial stage. The investments are typically in forms of equity. The investment size generally ranges from US$2 million to US$10 million. The firm primarily invests in companies across China, but it will also consider Medical Devices that have attained approval to enter the market in China.

The firm is currently looking for new opportunities in the Medical Technology and Diagnostics sectors. The firm is open to all classes of medical devices and it is opportunistic in terms of indications. The firm is particularly interested in companies with products that are completing or have already completed China regulatory approvals and are preparing to enter the Chinese market. It is also interested in companies with products already on the market. The firm focuses on the phase of development more than the products.

The firm generally invests in private companies with a strong management team and significant growth potential. The firm will consider make PIPE investments on a case-by-case basis. The firm looks to take a board seat.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: